Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    Reye's Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Reye's Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Intracranial Hypertension and Optic Nerve Sheath Diameter
Conditions: Cerebral Stroke;   Cerebral Venous Thrombosis
Intervention: Other: ONSD ultrasound
2 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
3 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
4 Completed Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Procedure: Preterm fetus
5 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
6 Completed Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Conditions: ACS;   Acute Coronary Syndrome;   Myocardial Infarction;   Unstable Angina;   Coronary Artery Disease
7 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
8 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
9 Terminated
Has Results
Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
10 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab;   Drug: Placebo
11 Completed The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Darapladib 160 mg;   Drug: Placebo;   Other: Standard Therapy
12 Completed Colloids in Severe Trauma
Conditions: Abdominal Hypertension;   Abdominal Compartment Syndrome;   Severe Trauma
Intervention: Drug: tetrastarch (Voluven)
13 Completed A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Aleglitazar;   Drug: Placebo
14 Terminated L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
Condition: Pre-Eclampsia
Interventions: Procedure: L-arginine supplementation in a medical food;   Procedure: Vitamin C and E supplementation in a medical food
15 Unknown  PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: zidovudine+lamivudine+lopinavir/ritonavir;   Drug: zidovudine + lamivudine + efavirenz
16 Completed Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
Condition: Prostatic Cancer
17 Terminated Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
18 Unknown  6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
Condition: Multiple Organ Dysfunction Syndrome
Intervention: Drug: 6-methyl-prednisolone
19 Completed
Has Results
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
20 Recruiting Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Metformin;   Dietary Supplement: Magnesium;   Dietary Supplement: PUFA

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years